Form D · Pharmaceuticals
Tetra Bio-Pharma Inc.
Orleans, Ontario, Z4 · CIK 0001814888
Offering snapshot reported Jun 12, 2020 · SEC filing
- Reported sold
- $371K Offering amount: $371K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 22, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 12, 2020 | Initial | $371,020 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $26K
- Finders' fees
- $0
- Form D file number
- 021-368793
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| CANACCORD GENUITY LLC | 1020 | CANACCORD GENUITY LLC · CRD 1020 |
Source: Form D, filed Jun 12, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Guy Chamberland | Executive |
| Bill Cheliak | Director |
| Sabino Di Paola | Executive |
| Gregory Drohan | Director |
| Carl Merton | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2316 St. Joseph Blvd.
Orleans, Ontario, Z4, K1C 1E8
Orleans, Ontario, Z4, K1C 1E8